Clinical trial
The Dutch Multicentre Study Into Opportunistically Screening Geriatric Patients for Atrial Fibrillation Using a PPG Smartphone App; the Dutch-GERAF Study
NCT05337202 is registered in ClinicalTrials.gov with Dijklander Ziekenhuis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Dutch Multicentre Study Into Opportunistically Screening Geriatric Patients for Atrial Fibrillation Using a PPG Smartphone App; the Dutch-GERAF Study
- Lead sponsor
- Dijklander Ziekenhuis
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 25, 2021
- Completion date
- June 30, 2026
- Enrollment
- 1,075 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation, frailty, major bleed